303 related articles for article (PubMed ID: 16359125)
1. Kinetics of humoral immune response in pigs vaccinated against foot and mouth disease.
Sharma M; Kadian SK; Sharma R; Rana TS
Indian J Exp Biol; 2005 Dec; 43(12):1144-9. PubMed ID: 16359125
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
3. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
[TBL] [Abstract][Full Text] [Related]
4. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
[TBL] [Abstract][Full Text] [Related]
5. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
7. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
[TBL] [Abstract][Full Text] [Related]
8. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
[TBL] [Abstract][Full Text] [Related]
9. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge.
Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM
Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
11. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
[TBL] [Abstract][Full Text] [Related]
12. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
13. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
14. Cedivac-FMD can be used according to a marker vaccine principle.
Chénard G; Selman P; Dekker A
Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
[TBL] [Abstract][Full Text] [Related]
15. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.
Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P
J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus.
Eblé PL; Bouma A; de Bruin MG; van Hemert-Kluitenberg F; van Oirschot JT; Dekker A
Vaccine; 2004 Mar; 22(11-12):1372-8. PubMed ID: 15063559
[TBL] [Abstract][Full Text] [Related]
18. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost.
Li Y; Stirling CM; Denyer MS; Hamblin P; Hutchings G; Takamatsu HH; Barnett PV
Vaccine; 2008 May; 26(21):2647-56. PubMed ID: 18321615
[TBL] [Abstract][Full Text] [Related]
19. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
Niedbalski W
Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
[TBL] [Abstract][Full Text] [Related]
20. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
